Skip to content
Dr. Tashko’s badge from the Better Business Bureau displays an “Accredited Business” seal with an A+ rating as of July 9, 2025 for GT Health practice. The design features the BBB torch logo on the left and a clickable prompt for profile access on the right, reinforcing professional credibility, transparency, and excellence in patient care and business ethics.
🗨️ Text Us Securely

Fees | Join Our Practice

  • Home
  • Dr. Tashko
    • Profile
    • My Philosophy
    • Featured in Montgomery Magazine
    • Featured in Washingtonian
    • Publications
  • Reviews
  • Benefits
    • Personalized & Integrative Care
    • Our Unique Approach
    • FAQs
  • Services
    • Endocrinology
    • Diabetes
    • Lipidology
    • Hypertension
    • Weight Loss
    • Heart
    • Women’s Health
    • Testosterone, TRT
    • Thyroid
    • Parathyroid
    • Adrenal
    • Pituitary
    • Gynecomastia
    • PCOS
    • Osteoporosis
    • Calcium
    • Longevity
    • Clinical Trials
    • Energy Metabolism
    • Fitness
    • More…
  • Become a Patient
    • Join Our Practice
    • Fees
    • A Letter to My Patients
  • Resources
    • Articles and Posts
    • Key Clinical Trials
    • Clinical Guidelines
    • Personal Interests
    • Search 🔎
  • Contact Us

Semaglutide Patient Information

  • Semaglutide’s Double Power for Weight Loss and Knee Pain

    Semaglutide’s Double Power for Weight Loss and Knee Pain

    The study, Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis, explores the impact of weekly semaglutide injections. It focuses on weight loss and pain relief for people with obesity and knee osteoarthritis (OA)

    Published

    November 12, 2024
    Categorized as Dr. Tashko’s Key Clinical Trials, Joint Health, Semaglutide Patient Information, Weight Loss
  • Link Between Weight Gain & Sleep Apnea

    Link Between Weight Gain & Sleep Apnea

    Weight gain, especially when it results in obesity, is a main risk factor for obstructive sleep apnea. Excess body weight can cause fat accumulation around the neck, which can narrow the airway. This physical constriction makes it more likely for the airway to collapse during sleep, causing pauses and shallow breaths.

    Published

    July 25, 2024
    Categorized as Insights from Dr. Tashko, Obesity Care, Semaglutide Patient Information, Sleep Health, Tirzepatide Patient Information, Weight Loss
  • FLOW Study Highlights: How Semaglutide Improves Outcomes in Diabetes and CKD

    FLOW Study Highlights: How Semaglutide Improves Outcomes in Diabetes and CKD

    Here, I provide a brief summary of the FLOW study on semaglutide’s effects in patients with type 2 diabetes and chronic kidney disease. This study highlights the benefits of semaglutide in reducing the risks of kidney failure, cardiovascular events, and death. We will delve into the key findings and results published in the New England Journal of Medicine in May 2024.

    Published

    May 27, 2024
    Categorized as Diabetes Care, Dr. Tashko’s Key Clinical Trials, Kidney Health, Semaglutide Patient Information
  • Mounjaro vs. Ozempic: Which Is Best for Shedding Unwanted Pounds?

    Mounjaro vs. Ozempic: Which Is Best for Shedding Unwanted Pounds?

    Some of today’s top injections include Mounjaro and Ozempic, both of which have produced amazing results. Wondering if Mounjaro or Ozempic is best for you?

    Published

    April 23, 2024
    Categorized as Blog, Semaglutide Patient Information, Tirzepatide Patient Information, Weight Loss
  • STEP Study: Semaglutide’s Impact on Heart Failure, Obesity, and Type 2 Diabetes

    STEP Study: Semaglutide’s Impact on Heart Failure, Obesity, and Type 2 Diabetes

    Semaglutide benefits obesity-related heart failure in type 2 diabetes, improving symptoms and aiding weight loss. The STEP trial evaluated the effects of semaglutide (Ozempic or Wegovy) 2.4 mg weekly in participants with heart failure, obesity, and type 2 diabetes. Patients received either semaglutide or placebo for 52 weeks.

    Published

    April 6, 2024
    Categorized as Diabetes Care, Dr. Tashko’s Key Clinical Trials, Drug Information, Heart Health, Obesity Care, Semaglutide Patient Information
  • SELECT Study: Semaglutide Reduces Cardiovascular Risk in Obesity and Prediabetes

    SELECT Study: Semaglutide Reduces Cardiovascular Risk in Obesity and Prediabetes

    Semaglutide, marketed as Ozempic or Wegovy and administered at a weekly dosage of 2.4 mg, has demonstrated a noteworthy reduction in cardiovascular events by 20% among non-diabetic individuals with obesity. Most participants had a diagnosis of prediabetes and a history of either myocardial infarction (MI) or stroke at the beginning of the study.

    Published

    March 16, 2024
    Categorized as Dr. Tashko’s Key Clinical Trials, Heart Health, Obesity Care, Semaglutide Patient Information, Weight Loss
  • How Safe Is Ozempic for Long-Term Use?

    How Safe Is Ozempic for Long-Term Use?

    There is no shortage of information and praise regarding weight loss injections. But, how long can you take them before you hit a plateau?

    Published

    January 31, 2024
    Categorized as Blog, Semaglutide Patient Information
  • 4 Insider Tips to Find the Best Semaglutide and Weight Loss Doctor In Bethesda

    4 Insider Tips to Find the Best Semaglutide and Weight Loss Doctor In Bethesda

    Follow these tips and you’ll be on your way to success in finding the best semaglutide and weight loss doctor in Bethesda, MD.

    Published

    October 27, 2023
    Categorized as Blog, Semaglutide Patient Information, Weight Loss
  • What is Insulin Resistance?

    What is Insulin Resistance?

    Insulin resistance is a condition in which the body’s cells become less responsive to the effects of insulin, a hormone produced by the beta cells in the pancreas. Insulin is central for regulating blood sugar (glucose) levels, facilitating the uptake of glucose by cells for energy.

    Published

    October 6, 2023
    Categorized as Diabetes Care, Heart Health, Hypertension, Inflammation-Related Conditions, Insights from Dr. Tashko, Lipid Health, MetSynX, NASH, Obesity Care, Semaglutide Patient Information
  • How Much Does Semaglutide Cost in Bethesda, MD?

    How Much Does Semaglutide Cost in Bethesda, MD?

    Weight loss injections are relatively new, and the prices can vary. So, how much does semaglutide cost in Bethesda, MD from a weight loss specialist?

    Published

    September 26, 2023
    Categorized as Blog, Semaglutide Patient Information
  • Same-Day Weight Loss Injections in Rockville, Maryland: How Long Does It Take Them to Work?

    Same-Day Weight Loss Injections in Rockville, Maryland: How Long Does It Take Them to Work?

    Same-day weight loss injections in Rockville, Maryland may just be the jump start you need to reach your goals.

    Published

    September 26, 2023
    Categorized as Blog, Semaglutide Patient Information, Weight Loss
  • Here’s How to Find the #1 Ozempic Doctor in Rockville, MD

    Here’s How to Find the #1 Ozempic Doctor in Rockville, MD

    Before embarking on your journey to lose weight, it’s important you find the #1 Ozempic doctor in Rockville, MD.

    Published

    September 26, 2023
    Categorized as Blog, Semaglutide Patient Information
Older posts ➡

The only US physician board-certified in:

❥ Endocrinology, Diabetes and Metabolism

❥ Obesity Medicine

❥ Hypertension

❥ Lipidology

Dr. Tashko’s badge from the Better Business Bureau displays an “Accredited Business” seal with an A+ rating as of July 9, 2025 for GT Health practice. The design features the BBB torch logo on the left and a clickable prompt for profile access on the right, reinforcing professional credibility, transparency, and excellence in patient care and business ethics.
🗨️ Text Our Office Securely

T

301.658.3586

F

240.427.4704

E

admin@GThealth.net

15204 Omega Drive
Suite 240
Rockville, MD 20850

Dr. Tashko is quadruple board-certified in endocrinology, lipidology, hypertension, and obesity medicine. He specializes in diabetes, metabolism, and longevity care, offering integrative, evidence-based solutions for insulin resistance, metabolic syndrome, prediabetes, obesity, and weight management.

He provides advanced cardiovascular prevention and lipid management, focusing on precise control of blood pressure, cholesterol, and triglycerides.

His endocrine expertise covers thyroid and parathyroid disorders, pituitary and adrenal conditions, growth hormone deficiency, Cushing’s syndrome, hyperprolactinemia, and bone health issues such as osteopenia and osteoporosis.

Dr. Tashko also treats low testosterone (TRT), gynecomastia, and polycystic ovary syndrome (PCOS). Each patient receives comprehensive, personalized care centered on metabolic and hormonal balance.

GT Health is based in Rockville, Montgomery County, MD, and serves patients throughout Bethesda, Chevy Chase, Potomac, Gaithersburg, Germantown, Frederick, Silver Spring, Howard County, Anne Arundel, Northern Virginia, and the Eastern Shore. GT Health provides concierge endocrine and metabolic care in Rockville and across Maryland through secure virtual visits.

Medical Conditions
  • Facebook
  • Google
  • LinkedIn
  • Twitter

Copyright

© 2017–2026

Gerti Tashko, M.D.

All Rights Reserved.

“In him all things hold together.”
— Col 1:17